Schering-Plough's Aerius/NeoClarityn approved in E.U. for treatment of seasonal allergic rhinitis Jan. 18, 2001
Soluble inhibitors of protein kinase C designed at AstraZeneca for wide range of disorders Jan. 12, 2001